首页> 外文期刊>Diabetes research and clinical practice >Comparison of National Diabetes Data Group and American Diabetes Association diagnostic criteria for gestational diabetes in their identification of postpartum risk of glucose intolerance.
【24h】

Comparison of National Diabetes Data Group and American Diabetes Association diagnostic criteria for gestational diabetes in their identification of postpartum risk of glucose intolerance.

机译:美国国家糖尿病数据组和美国糖尿病协会针对妊娠糖尿病的诊断标准在确定产后葡萄糖耐受不良风险方面的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: Gestational diabetes mellitus (GDM) is associated with adverse obstetrical outcomes and postpartum pre-diabetes/diabetes. As the American Diabetes Association (ADA) criteria for GDM may capture obstetrical risk better than the National Diabetes Data Group (NDDG) criteria, we compared these criteria in their detection of postpartum risk of glucose intolerance. METHODS: 487 Women underwent oral glucose tolerance test in pregnancy and at 3-month postpartum. Participants were stratified into the following 5 groups: normal glucose tolerance (NGT) by both ADA and NDDG; gestational impaired glucose tolerance (GIGT) by ADA only; GIGT by both ADA and NDDG; GDM by ADA only; and GDM by both ADA and NDDG. RESULTS: The prevalence of postpartum glucose intolerance (pre-diabetes/diabetes) varied across the groups (NGT by both ADA and NDDG: 5.9%; GIGT by ADA only: 14.3%; GIGT by both ADA and NDDG: 10.6%; GDM by ADA only: 21.6%; GDM by both ADA and NDDG: 32.8%; overall p<0.0001). Importantly, however, for predicting postpartum pre-diabetes/diabetes, abnormal antepartum glucose tolerance by NDDG and ADA, respectively, exhibited comparable positive predictive value (26% vs. 24%) and area-under-the-receiver-operating-characteristic-curve (0.67 vs. 0.66, p=0.63). CONCLUSIONS: Unlike with obstetrical outcomes, NDDG and ADA criteria for GDM are similar in their ability to identify postpartum metabolic risk.
机译:目的:妊娠期糖尿病(GDM)与不良的产科预后和产后糖尿病/糖尿病有关。由于美国糖尿病协会(ADA)的GDM标准可能比美国国家糖尿病数据组(NDDG)的标准更好地把握了产科风险,因此我们比较了这些标准在检测产后葡萄糖耐受不良风险中的作用。方法:487名孕妇在妊娠和产后3个月接受了口服葡萄糖耐量试验。参与者分为以下5组:ADA和NDDG的正常葡萄糖耐量(NGT);仅由ADA引起的妊娠糖耐量异常(GIGT); ADA和NDDG的GIGT;仅适用于ADA的GDM;以及ADA和NDDG的GDM。结果:各组的产后葡萄糖耐量异常(糖尿病前/糖尿病)的发生率各不相同(ADA和NDDG分别为NGT:5.9%; ADA仅为GIGT:14.3%; ADA和NDDG均为GIGT:10.6%; GDM分别为仅ADA:21.6%; ADA和NDDG的GDM:32.8%;总体p <0.0001)。但是,重要的是,对于预测产后糖尿病前期/糖尿病,NDDG和ADA分别对异常的产前葡萄糖耐量表现出可比的阳性预测值(26%vs. 24%)和受试者工作特征下的面积-曲线(0.67 vs.0.66,p = 0.63)。结论:与产科预后不同,NDDG和ADA的GDM标准在识别产后代谢风险的能力方面相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号